Mechanisms of inactivation of E-cadherin in breast cancer cell lines

Cancer Research

Volumn 58, Issue 9, 1998, Pages 1972-1977

  Hiraguri, Shunsuke ^a   Godfrey, Tony ^a   Nakamura, Haruhiko ^a   Graff, Jeremy ^a,b   Collins, Collin ^c   Shayesteh, Laleh ^a   Doggett, Norman ^d   Johnson, Keith ^e   Wheelock, Margaret ^e   Herman, James ^b   Baylin, Stephen ^b   Pinkel, Daniel ^a   Gray, Joe ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ALLELE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; TRANSCRIPTION REGULATION;

ALLELES; BREAST NEOPLASMS; CADHERINS; DNA METHYLATION; DNA PRIMERS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032080669     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Papkoff, J. Regulation of complexed and free catenin pools by distinct mechanisms: differential effects of Wnt-1 and v-Src. J. Biol. Chem., 272: 4536-4543, 1997.
2. Ilyas, M., and Tomlinson, I. P. The interactions of APC, E-cadherin, and β-catenin in tumour development and progression. J. Pathol., 182: 128-137, 1997.
3. Frixen, U . H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
4. Sato, T., Akiyama, F., Sakamoto, G., Kasumi, F., and Nakamura, Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res., 51: 5794-5799, 1991.
5. Cleton-Jansen, A. M., Moerland, E. W., Kuipers-Dijkshoorn, N. J., Callen, D. F., Sutherland, G. R., Hansen, B., Devilee, P., and Cornelisse, C. J. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer, 9: 101-107, 1994.
6. Lindblom, A., Rotstein, S., Skoog, L., Nordenskjold, M., and Larsson, C. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res., 53: 3707-3711, 1993.
7. Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., and Funke I. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res., 53: 1690-1695, 1993.
8. Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F., Schaafsma, H. E., Debruyne, F. M., and Isaacs, W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52: 5104-5109, 1992.
9. Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quintanilla, M., and Cano, A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol., 142: 987-993, 1993.
10. Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., Takeichi, M., and Mori, T. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53: 1696-1701, 1993.
11. Giroldi, L. A., and Schalken, J. A. Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev., 12: 29-37, 1993.
12. Umbas, R., Isaacs, W. B., Bringuier, P. P., Schaafsma, H. E., Karthaus, H. F., Oosterhof, G. O., Debruyne, F. M., and Schalken, J. A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929-3933, 1994 .
13. Bringuier, P. P., Umbas, R., Schaafsma, H. E., Karthaus, H. F., Debruyne, F. M., and Schalken, J. A. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res., 53: 3241-3245, 1993.
14. Oda, T., Kanai, Y., Oyama, T., Yoshiura, K., Shimoyama, Y., Birchmeier, W., Sugimura, T., and Hirohashi, S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 91: 1858-1862, 1994.
15. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., and Hofler, H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54: 3845-3852, 1994.
16. Risinger, J. I., Berchuck, A., Kohler, M. K., and Boyd, J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat. Genet., 7: 98-102, 1994.
17. Pierceall, W., Woodard, A., Morrow, J., Rimm, D., and Fearon, E. Frequent alterations in E-cadherin and α-and β-catenin expression in human breast cancer cell lines. Oncogene, 11: 1319-1326, 1995.
18. Berx, G., Cleton-Jansen, A. M., Strumane, K., de Leeuw, W. J., Nollet, F., van Roy, F., and Cornelisse, C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene, 13: 1919-1925, 1996.
19. Mbalaviele, G., Dunstan, C. R., Sasaki, A., Williams, P. J., Mundy, G. R., and Yoneda, T. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res., 56: 4063-4070, 1996.
20. Bracke, M. E., Charlier, C., Bruyneel, E. A., Labit, C., Mareel, M. M., and Castronovo, V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res., 54: 4607-4609, 1994.
21. Anzano, M. A., Byers, S. W., Smith, J. M., Peer, C. W., Mullen, L. T., Brown, C. C., Roberts, A. B., and Sporn, M. B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res., 54: 4614-4617, 1994.
22. Jiang, W., Hiscox, S., Hallett, M., Horrobin, D., Mansel, R., and Puntis, M. Regulation of the expression of E-cadherin on human cancer cells by γ-linolenic acid (GLA). Cancer Res., 55: 5043-5048, 1995.
23. Bracke, M. E., Vyncke, B. M., Bruyneel, E. A., Vermeulen, S. J., De Bruyne, G. K., Van Larebeke, N. A., Vleminckx, K., Van Roy, F. M., and Mareel, M. M. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer, 68: 282-289, 1993.
24. Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., and Bissell, M. J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integral blocking antibodies. J. Cell Biol., 137: 231-245, 1997.
25. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., and Hirohashi, S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 7416-7419, 1995.
26. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-speciftc PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
27. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55: 5195-5199, 1995.
28. Bussemakers, M. J., Giroldi, L. A., van Bokhoven, A., and Schalken, J. A. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. Biochem. Biophys. Res. Commun., 203: 1284-1290, 1994.
29. Chumakov, I., Rigault, P., Le Gall, I., et al., and Cohen, D. A YAC contig map of the human genome. Nature (Lond.), 377 (Suppl.): 174-297, 1995.
30. Mascio, L. N., Verbeek, P. W., Sudar, D., Kuo, W. L., and Gray, J. W. Semiautomated DNA probe mapping using digital imaging microscopy: I. System development. Cytometry, 19: 51-59, 1995.
31. Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., and Gray, J. W. erbB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
32. Wheelock, M., Buck, C., Bechtol, K., and Damsky, C. Soluble 80-kD fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J. Cell. Biochem., 34: 187-202, 1987.
33. Bussemakers, M. J., van Bokhoven, A., Mees, S. G., Kemler, R., and Schalken, J. A. Molecular cloning and characterization of the human E-cadherin cDNA. Mol. Biol. Rep., 17: 123-128, 1993.
34. Berk, G., Staes, K., Hengel, J., Molemans, F., Bussemakers, M., van Bokhoven, A., and van Roy, F. Cloning and characterization of the human suppressor gene E-cadherin (CHD1). Genomics, 26: 281-289, 1995.
35. Fischer, S. G., and Lerman, L. S. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc. Natl. Acad. Sci. USA, 80: 1579-1583, 1983.
36. Matsumura, K., Kallioniemi, A., Kallioniemi, O., Chen, L., Smith, H. S., Pinkel, D., Gray, J., and Waldman, F. M. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res., 52: 3474-3477,1992.
37. Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., and Jensen, R. H. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56: 3091-3102, 1996.
38. Knudson, A. G., Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
39. 2+ ending site of uvomorulin abolish the adhesive function. Cell, 63: 1033-1038, 1990.